New agreements will benefit FSU students interested in Engineering, Data Science, Medicinal Chemistry and Neuroscience.
Framingham, Massachusetts, is a vibrant city just 20 miles west of Boston. Known for its blend of suburban charm and urban amenities, it attracts residents who seek a balance between city life and ...
FRAMINGHAM - Under Friday night lights, the Framingham Flyers varsity cheerleaders keep spirits high from the sidelines. And it is their spirit - not competitive, but caring - that is so worth ...
French pharma giant Sanofi is selling off its consumer healthcare business Opella. US-based investment firm Clayton, Dubilier & Rice (CD&R) is to take a controlling 50% stake, while Sanofi will retain ...
(RTTNews) - Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this fall. The administration ...
The former head of cancer drugmaker Seagen has joined a new startup involved in what’s recently become a competitive corner of oncology research. The startup, Ottimo Pharma, emerged from stealth ...
FRAMINGHAM, Mass. — The two-week-old piglet found abandoned in Framingham earlier this week is in good hands. The Animal Rescue League of Boston (ARL) says Magnolia was turned over to them by ...
Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in ...
Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...
Sanofi expects a low single-digit decline in flu shot sales due to the soft vaccination rate. Sanofi reaffirms that Dupixent will deliver around 13 billion euros in 2024 sales. The company ...
Oct 25 (Reuters) - French drug maker Sanofi (SASY.PA), opens new tab on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted by an earlier-than ...
Agomab Therapeutics is benefiting from Sanofi’s push to become an immunology powerhouse.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback